We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cyprotex Acquires CeeTox

News   Jan 02, 2014

 
Cyprotex Acquires CeeTox
 
 
Advertisement
 

RELATED ARTICLES

Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 Treatment

News

Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.

READ MORE

Anti-malarial Drug Shows Potential as Brain Cancer Treatment in Preclinical Models

News

In vitro studies have uncovered new insights that could help increase the effectiveness of the most common current treatments with the addition of lumefantrine, an FDA-approved drug used to treat malaria.

READ MORE

Not Enough Women and Older Adults in Cholesterol Drug Trials, Study Suggests

News

Johns Hopkins Medicine researchers report that although some progress has been made, women and older adults are still underrepresented in lipid lowering therapy trials compared with their disease burden.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE